Unum Group (NYSE:UNM) Receives Average Recommendation of “Moderate Buy” from Analysts

Unum Group (NYSE:UNM) has been assigned a consensus rating of “Moderate Buy” from the twelve research firms that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is $72.09.

UNM has been the topic of a number of research reports. Evercore ISI upgraded Unum Group from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $67.00 to $84.00 in a report on Thursday, November 14th. Truist Financial lifted their price objective on shares of Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Bank of America increased their target price on shares of Unum Group from $54.00 to $63.00 and gave the stock a “neutral” rating in a research report on Thursday, October 10th. JPMorgan Chase & Co. decreased their price target on Unum Group from $65.00 to $63.00 and set an “overweight” rating for the company in a research note on Thursday, October 3rd. Finally, Jefferies Financial Group raised their price objective on Unum Group from $91.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, December 10th.

Insider Buying and Selling at Unum Group

In other Unum Group news, EVP Elizabeth Claire Ahmed sold 5,000 shares of the business’s stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $64.16, for a total value of $320,800.00. Following the sale, the executive vice president now owns 58,741 shares of the company’s stock, valued at $3,768,822.56. The trade was a 7.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Christopher W. Pyne sold 3,250 shares of Unum Group stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $70.02, for a total transaction of $227,565.00. Following the sale, the executive vice president now owns 50,762 shares in the company, valued at approximately $3,554,355.24. This trade represents a 6.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 107,914 shares of company stock valued at $7,998,745 in the last ninety days. Company insiders own 0.93% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Versant Capital Management Inc raised its holdings in shares of Unum Group by 26.4% in the 4th quarter. Versant Capital Management Inc now owns 766 shares of the financial services provider’s stock worth $56,000 after buying an additional 160 shares in the last quarter. CIBC Asset Management Inc grew its position in Unum Group by 3.4% in the third quarter. CIBC Asset Management Inc now owns 5,551 shares of the financial services provider’s stock valued at $330,000 after acquiring an additional 180 shares during the period. V Square Quantitative Management LLC raised its stake in Unum Group by 38.2% during the third quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock worth $42,000 after acquiring an additional 194 shares in the last quarter. Brooklyn Investment Group lifted its holdings in shares of Unum Group by 3.1% during the third quarter. Brooklyn Investment Group now owns 6,592 shares of the financial services provider’s stock valued at $392,000 after acquiring an additional 197 shares during the period. Finally, Benjamin F. Edwards & Company Inc. boosted its stake in shares of Unum Group by 2.2% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 10,126 shares of the financial services provider’s stock valued at $518,000 after purchasing an additional 217 shares in the last quarter. Institutional investors own 86.57% of the company’s stock.

Unum Group Trading Up 0.2 %

Shares of NYSE:UNM opened at $73.10 on Tuesday. The firm has a fifty day moving average of $72.04 and a two-hundred day moving average of $61.23. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a 12-month low of $44.83 and a 12-month high of $77.63. The firm has a market capitalization of $13.35 billion, a P/E ratio of 7.91, a price-to-earnings-growth ratio of 1.06 and a beta of 0.81.

Unum Group (NYSE:UNM) last issued its earnings results on Tuesday, October 29th. The financial services provider reported $2.13 EPS for the quarter, beating analysts’ consensus estimates of $2.10 by $0.03. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. The firm had revenue of $3.22 billion for the quarter, compared to the consensus estimate of $3.26 billion. During the same quarter in the previous year, the company posted $1.94 earnings per share. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. On average, equities analysts expect that Unum Group will post 8.54 EPS for the current fiscal year.

Unum Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 25th were paid a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 2.30%. The ex-dividend date was Friday, October 25th. Unum Group’s payout ratio is currently 18.18%.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.